Extensive studies have shown that KRAS upregulation is associated with various malignancies, including lung adenocarcinoma, ductal carcinoma of the pancreas, colorectal carcinoma, and breast carcinoma [4, 5]. The gene discussed is KRAS; the disease is breast carcinoma.